UnknownNot Applicable

Sensitivity of Targeted Biopsy Within Sydney Protocol for GIM

Thailand105 participantsStarted 2019-11-01

Plain-language summary

Sensitivity of Targeted Biopsy Within Sydney Protocol by Using Narrow Band Imaging for Extensive Gastric Intestinal Metaplasia Diagnosis Objective: The aim of this study is to evaluate the sensitivity of targeted biopsy within Sydney protocol by using narrow band imaging for Extensive Gastric Intestinal Metaplasia diagnosis Research design: Diagnosis study Sample size: 105 cases Data analysis: The outcomes will be presented using 2 by 2 tables and if the data are normal distribution the categorical data will be analysed using McNemar's test

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * At least 18 year of age * Suspected GIM by previous tissue pathology * Able to provide informed consent for participation Exclusion Criteria: * Previous gastric surgery including gastrectomy and bypass surgery * Coagulopathy * Pregnancy * Active upper GI bleeding

What they're measuring

Sensitivity of targeted biopsy within Sydney protocol by using narrow band imaging for Extensive Gastric Intestinal Metaplasia diagnosis

Timeframe: 4 weeks after completing the enrollment.

Trial details

NCT IDNCT04331951

SponsorKing Chulalongkorn Memorial Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-07-31

Contact for this trial

Rapat Pittayanon, MD

66804224999 rapat125@gmail.com

View on ClinicalTrials.gov More Intestinal Metaplasia trials